Efficacy of the Pan-Bcl-2 Inhibitor (Obatoclax) As a Single Agent to Treat Myeloproliferative Neoplasm in JAK2V617F Murine Transplantation Model

被引：0
|
作者：
Bianco, Thiago Mantello [1 ]
Coelho-Silva, Juan L. [2 ,3 ,4 ]
Pereira-Martins, Diego A. [2 ,5 ]
Scheucher, Priscila Santos [1 ]
Weinhauser, Isabel [2 ]
Alves Silva, Antonio Bruno [1 ,2 ]
Silva, Cleide Lucia [2 ]
Mullally, Ann [6 ]
Kobayashi, Susumu S. [7 ,8 ]
Rego, Eduardo M. [2 ,9 ]
Traina, Fabiola [1 ,2 ]
Figueiredo-Pontes, Lorena Lobo [1 ,2 ]
机构：
[1] Univ Sao Paulo, Ribeirao Preto Med Sch, Div Hematol, Dept Med Images Hematol & Clin Oncol, Ribeirao Preto, Brazil
[2] Univ Sao Paulo, Ribeirao Preto Med Sch, Ctr Cell Based Therapy & Reg Hemotherapy Ctr, Ribeirao Preto, SP, Brazil
[3] Univ Sao Paulo, Ribeirao Preto Med Sch, Hematol Div Med Images, Ribeirao Preto, Brazil
[4] Univ Sao Paulo, Ribeirao Preto Med Sch, Clin Oncol Dept, Ribeirao Preto, Brazil
[5] Univ Sao Paulo, Med Sch Ribeirao Preto, Div Hematol, Dept Internal Med, Ribeirao Preto, Brazil
[6] Brigham & Womens Hosp, Div Hematol, 75 Francis St, Boston, MA 02115 USA
[7] Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02215 USA
[8] Harvard Med Sch, Boston, MA 02115 USA
[9] Univ Sao Paulo, Med Sch, Hosp Clin, Div Hematol,Fac Med HCFMUSP, Sao Paulo, Brazil
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131023
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2977
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Stat3 Negatively Regulates Myeloproliferative Neoplasm Induced By Jak2V617F
    Yan, Dongqing
    Mohi, Golam
    BLOOD, 2013, 122 (21)
  • [22] Thrombosis in Myeloproliferative Neoplasms With JAK2V617F Mutation
    Sun, Tiantian
    Zhang, Lei
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2013, 19 (04) : 374 - 381
  • [23] PREVALENCE OF JAK2V617F MUTATION AND ITS CLINICAL CORRELATION IN THAIS WITH MYELOPROLIFERATIVE NEOPLASM
    Chanprasert, S.
    Suksomyos, N.
    Maunpasitporn, C.
    Ponlapat, R.
    HAEMATOLOGICA, 2012, 97 : 643 - 643
  • [24] Adrenal infarction with latent myelodysplastic/myeloproliferative neoplasm, unclassifiable with JAK2V617F mutation
    Yasuda, Shunichiro
    Chiba, Momoko
    Nishitani, Rie
    Watanabe, Takako
    CLINICAL CASE REPORTS, 2024, 12 (04):
  • [25] Granulocyte whole exome sequencing and endothelial JAK2V617F in patients with JAK2V617F positive Budd-Chiari Syndrome without myeloproliferative neoplasm
    Helman, Ricardo
    Pereira, Welbert de O.
    Marti, Luciana C.
    Campregher, Paulo V.
    Puga, Renato Davi
    Hamerschlak, Nelson
    Chiattone, Carlos S.
    Santos, Fabio Pires de S.
    BRITISH JOURNAL OF HAEMATOLOGY, 2018, 180 (03) : 443 - 445
  • [26] Erythrocyte-derived microvesicles induce arterial spasms in JAK2V617F myeloproliferative neoplasm
    Poisson, Johanne
    Tanguy, Marion
    Davy, Hortense
    Camara, Fatoumata
    El Mdawar, Marie-Belle
    Kheloufi, Marouane
    Dagher, Tracy
    Devue, Cecile
    Lasselin, Juliette
    Plessier, Aurelie
    Merchant, Salma
    Blanc-Brude, Olivier
    Souyri, Michele
    Mougenot, Nathalie
    Dingli, Florent
    Loew, Damarys
    Hatem, Stephane N.
    James, Chloe
    Villeval, Jean-Luc
    Boulanger, Chantal M.
    Rautou, Pierre-Emmanuel
    JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (05): : 2630 - 2643
  • [27] JAK2V617F myeloproliferative neoplasm eradication by a novel interferon/arsenic therapy involves PML
    Dagher, Tracy
    Maslah, Nabih
    Edmond, Valerie
    Cassinat, Bruno
    Vainchenker, William
    Giraudier, Stephane
    Pasquier, Florence
    Verger, Emmanuelle
    Niwa-Kawakita, Michiko
    Lallemand-Breitenbach, Valerie
    Plo, Isabelle
    Kiladjian, Jean-Jacques
    Villeval, Jean-Luc
    de The, Hugues
    JOURNAL OF EXPERIMENTAL MEDICINE, 2021, 218 (02):
  • [28] A report on the co-occurrence of JAK2V617F and CALR mutations in myeloproliferative neoplasm patients
    Na Xu
    Li Ding
    Changxin Yin
    Xuan Zhou
    Lin Li
    Yulin Li
    Qisi Lu
    Xiao-li Liu
    Annals of Hematology, 2015, 94 : 865 - 867
  • [29] The JAK2V617F mutation and the role of therapeutic agents in alleviating myeloproliferative neoplasm symptom burden
    Orbell, Lai Yee
    Abutheraa, Nouf
    Duncombe, Andrew S.
    Mcmullin, Mary Frances
    Mesa, Ruben
    Mcshane, Charlene M.
    James, Glen
    Anderson, Lesley A.
    EJHAEM, 2023, 4 (04): : 1071 - 1080
  • [30] JAK2V617F somatic mutation in the general population: myeloproliferative neoplasm development and progression rate
    Nielsen, Camilla
    Bojesen, Stig E.
    Nordestgaard, Borge G.
    Kofoed, Klaus F.
    Birgens, Henrik S.
    HAEMATOLOGICA, 2014, 99 (09) : 1448 - 1455
12345